PASG
Passage BIO, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.65
+3.55%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-810.4%
Return on equity
-143.4%
Return on assets
-889.9%
Return on invested capital
0.00x
Asset turnover
-$33.5M
Cash from operations
$7.51
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026